Home › Cancro metastatico › California › Mountain View
Studi clinici su Cancro metastatico a Mountain View, CA
25 studi su Cancro metastatico cercano partecipanti presso sedi a Mountain View e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
In reclutamentoFase 2
- Stanford Cancer Institute Palo Alto, Palo Alto · a 5 mi di distanza
- VA Palo Alto Health Care System, Palo Alto · a 5 mi di distanza
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
In reclutamentoFase 1/2
- Stanford, Palo Alto · a 5 mi di distanza
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
In reclutamentoFase 2/3
- Stanford Cancer Center, Palo Alto · a 5 mi di distanza
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
In reclutamentoFase 3
- Palo Alto Medical Foundation - Palo Alto Center, Palo Alto · a 5 mi di distanza
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
In reclutamentoFase 1/2
- Stanford Medicine, Palo Alto · a 5 mi di distanza
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
In reclutamentoFase 1
- Stanford Cancer Institute, Stanford · a 5 mi di distanza
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
In reclutamentoFase 1
- Stanford University Medical Center, Stanford · a 5 mi di distanza
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
In reclutamentoFase 3
- Stanford Women's Cancer Center, Palo Alto · a 5 mi di distanza
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
In reclutamentoFase 3
- Stanford Cancer Center, Palo Alto · a 5 mi di distanza
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
In reclutamentoFase 1/2
- Stanford Cancer Institute, Stanford · a 5 mi di distanza
Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases.
In reclutamentoFase 2
- Stanford University, Palo Alto · a 5 mi di distanza
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
In reclutamentoFase 3
- Research Site, Palo Alto · a 5 mi di distanza
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
In reclutamentoFase 1/2
- Stanford Cancer Institute (SCI), Stanford · a 5 mi di distanza
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
In reclutamentoFase 1
- Stanford Medicine Cancer Center, Stanford · a 5 mi di distanza
FOG-001 in Locally Advanced or Metastatic Solid Tumors
In reclutamentoFase 1/2
- Stanford Cancer Institute, Stanford University, Palo Alto · a 5 mi di distanza
Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases
In reclutamentoFase 3
- Stanford University School of Medicine, Palo Alto · a 5 mi di distanza
A Study of LY4175408 in Participants With Advanced Cancer
In reclutamentoFase 1
- Stanford Medicine Cancer Center, Stanford · a 5 mi di distanza
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
In reclutamentoFase 1/2
- Stanford Cancer Institute, Stanford · a 5 mi di distanza
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
In reclutamentoFase 2/3
- Stanford Health Care - Skin Cancer Program, Stanford · a 5 mi di distanza
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
In reclutamentoFase 2/3
- Stanford Cancer Institute, Palo Alto · a 5 mi di distanza
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
In reclutamentoFase 1
- Stanford Cancer Institute, Stanford · a 5 mi di distanza
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
In reclutamentoFase 1
- Stanford Cancer Institute, Stanford · a 5 mi di distanza
Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
In reclutamentoStudio osservazionale
- VA Palo Alto Healthcare System, Palo Alto · a 5 mi di distanza
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
In reclutamentoFase 1
- Stanford Cancer Institute, Palo Alto · a 5 mi di distanza
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Stanford · a 5 mi di distanza
Studi su Cancro metastatico in altre città
- Houston, TX104 studi
- New York City, NY93 studi
- Nashville, TN70 studi
- Boston, MA63 studi
- Los Angeles, CA57 studi
- St. Louis, MO54 studi
- Arlington, VA53 studi
- Philadelphia, PA46 studi
- Chicago, IL45 studi
- San Antonio, TX44 studi
- Washington, DC43 studi
- Dallas, TX42 studi
Altri studi a Mountain View
- Cancro (tutti i tipi)40 studi
- Cancro al seno26 studi
- Cancro del polmone non a piccole cellule21 studi
- Leucemia mieloide acuta19 studi
- Cancro ovarico19 studi
- Disturbo dello spettro autistico17 studi
- Cancro ai polmoni17 studi
- Cancro alla prostata15 studi
- Insufficienza cardiaca15 studi
- Autismo13 studi
- Leucemia linfoblastica acuta13 studi
- Cancro colorettale13 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.